Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

BTIG Research's Rating of Abbott Laboratories on 10/22/2026

On October 22, 2026, BTIG Research updated its outlook on Abbott Laboratories (NYSE:ABT) with the action "Lower Price Target", setting a price target of $125.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from BTIG Research

DateCompanyAction
10/22/2026
NextEra Energy, Inc. stock logo
NEE
NextEra Energy
Set Price Target
10/22/2026
NIKE, Inc. stock logo
NKE
NIKE
Reiterated Rating
10/22/2026
Sky Harbour Group Co. stock logo
SKYH
Sky Harbour Group
Reiterated Rating
10/22/2026
Booking Holdings Inc. stock logo
BKNG
Booking
Reiterated Rating
10/21/2026
Nexxen International Ltd. Sponsored ADR stock logo
NEXN
Nexxen International
Reiterated Rating
10/21/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated Rating
More Ratings From BTIG Research